0000950123-21-007096.txt : 20210517
0000950123-21-007096.hdr.sgml : 20210517
20210517164621
ACCESSION NUMBER: 0000950123-21-007096
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20210331
FILED AS OF DATE: 20210517
DATE AS OF CHANGE: 20210517
EFFECTIVENESS DATE: 20210517
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Column Group LLC
CENTRAL INDEX KEY: 0001833486
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20797
FILM NUMBER: 21931666
BUSINESS ADDRESS:
STREET 1: LETTERMAN DRIVE, BUILDING D, SUITE M-900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
BUSINESS PHONE: 415-865-2050
MAIL ADDRESS:
STREET 1: LETTERMAN DRIVE, BUILDING D, SUITE M-900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94129
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001833486
XXXXXXXX
03-31-2021
03-31-2021
false
The Column Group LLC
1 Letterman Drive
Building D, Suite M-900
San Francisco
CA
94129
13F HOLDINGS REPORT
028-20797
Y
Certain shares holdings that are reported on this 13F were previously reported on a 13F filed by Peter Svennilson (CIK: 0001606074) (File No. 028-16412)
James Evangelista
Chief Financial Officer
(415) 865-2050
/s/ James Evangelista
San Francisco
CA
05-17-2021
0
6
1043714
false
INFORMATION TABLE
2
4704.xml
INFORMATION TABLE FOR FORM 13F
Constellation Pharmaceuticals Inc.
COM
210373106
61437
2626631
SH
SOLE
0
2626631
0
Revolution Medicines Inc
COM
76155X100
164262
3580252
SH
SOLE
0
3580252
0
RAPT Therapeutics Inc
COM
75382E109
86262
3885679
SH
SOLE
0
3885679
0
ORIC Pharmaceuticals Inc.
COM
68622P109
116820
4768181
SH
SOLE
0
4768181
0
NGM Biopharmaceuticals Inc
COM
62921N105
447565
15396116
SH
SOLE
0
15396116
0
Nurix Therapeutics Inc
COM
67080M103
167368
5383333
SH
SOLE
0
5383333
0